跳至主要内容
临床试验/NCT05842980
NCT05842980招募中不适用

BIomarkers to Predict the Outcomes of Sepsis

Qilu Hospital of Shandong University1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000
试验地点
1
主要终点
28d all-cause mortality

研究概览

简要总结

Sepsis is an organ dysfunction syndrome caused by the host's immune response to infection, and is one of the common critical illnesses. However, sepsis remains the main threat to global health. Due to the high heterogeneity, the diagnosis of sepsis is difficult, and it is particularly important to find biomarkers that can predict changes in the patient's condition and prognosis. The purpose of this study is to collect patient blood samples for testing and identify biomarkers related to the prognosis of sepsis.

详细描述

Sepsis is an organ dysfunction syndrome caused by the host's immune response to infection, and is one of the common critical illnesses. There are reports that the mortality rate of sepsis patients is 25-30%, and the hospital mortality rate of septic shock is as high as 40-60%. According to Lancet data, in 2017, there were 48.9 million cases of sepsis worldwide, resulting in approximately 11 million deaths, accounting for 19.7% of the total global deaths. Surviving sepsis patients often experience secondary infections and chronic organ dysfunction, which affects their long-term quality of life and poses a huge socio-economic burden. The World Health Organization (WHO) has identified sepsis as a global health priority and called for improving the level of sepsis prevention and treatment. With the advancement of medical technology, the diagnostic and treatment guidelines for sepsis are constantly updated, and clinical treatment capabilities have been improved. However, sepsis remains the main threat to global health. Due to the high heterogeneity, the diagnosis of sepsis is difficult, and it is particularly important to find biomarkers that can predict changes in the patient's condition and prognosis. The purpose of this study is to collect patient blood samples for testing and identify biomarkers related to the prognosis of sepsis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The clinical diagnostic criteria for sepsis or septic shock that comply with the 3rd edition of the International Consensus on Sepsis and Sepsis Shock (Sepsis-3.0) are:
  • Sepsis-3.0 sepsis diagnosis criteria: infection or suspected infection with a Sequential Organ Failure Score (SOFA score) ≥ 2 points;
  • Sepsis-3.0 diagnostic criteria for septic shock: Sepsis with persistent hypotension, after sufficient fluid resuscitation, still requires vasopressor drugs to maintain average arterial pressure ≥ 65mmHg, and serum lactate level>2mmol/L (18mg/dL).
  • Age 18 to 85 years old

排除标准

  • patients with autoimmune disease, acquired immunodeficiency syndrome, agranulocytosis (<0.5 × 109/L), malignant tumors or other serious chronic diseases (heart failure, Liver failure, end-stage renal disease, etc.);
  • Receiving glucocorticoid treatment;
  • Refuse enrollment or give up active treatment. -

结局指标

主要结局

28d all-cause mortality

时间窗: 28 days

28d all-cause mortality

次要结局

  • all-cause mortality(90 days)
  • 28-day ICU-free days(28-day)
  • Sepsis liver injury(28-day)
  • Incidence of secondary infection(Day 0 to 28)
  • Sepsis renal injury(28-day)
  • Out-of-hospital mortality rate(Discharge for one year)
  • Hospital stays(90 days)
  • SOFA score(at days -1, 7, 14 and 28)
  • ICU mortality(90 days)
  • 28-day ventilator-free days(28-day)
  • 28-day CRRT-free days(28-day)
  • 28-day Vasoactive agents-free days(28-day)
  • Septic shock(28-day)
  • ICU stays(90 days)
  • re-hospitalization rate(90 days)
  • Sepsis heart injury(28-day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

BIomarkers to Predict the Outcomes of Sepsis | 临床试验